By making this change, we can manage health care costs more effectively and adapt to the increasing cost drivers within the health care industry. Just under 18,000 Point32 members use GLP-1 drugs for weight loss, the spokesperson said, not including those with plans through MassHealth, the states Medicaid program
Further, many available clinical-based studies had incomplete or an absence of details of the medication or patient demographics including medications, medical and/or surgical history, and other notable findings such as GI symptoms
Energy and fatigue management is another commonly cited rationale
Unlike many other glucose-lowering drugs, GLP-1 receptor agonists dont come with a relative contraindication for renal impairment
The rapid rise of GLP-1 medications like semaglutide and tirzepatide has reshaped conversations about weight, health and appetitebut a lot of research hasnt been done on these new drugs